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Abstract
The non-receptor tyrosine kinase Src and receptor tyrosine kinase epidermal growth factor receptor (EGFR/ErbB1) have
been established as collaborators in cellular signaling and their combined dysregulation plays key roles in human cancers,
including breast cancer. In part due to the complexity of the biochemical network associated with the regulation of these
proteins as well as their cellular functions, the role of Src in EGFR regulation remains unclear. Herein we present a new
comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cells. This
model, constructed manually from published biochemical literature, consists of 245 nodes representing proteins and their
post-translational modifications sites, and over 1,000 biochemical interactions. Using computer simulations of the model,
we find it is able to reproduce a number of cellular phenomena. Furthermore, the model predicts that overexpression of Src
results in increased endocytosis of EGFR in the absence/low amount of the epidermal growth factor (EGF). Our subsequent
laboratory experiments also suggest increased internalization of EGFR upon Src overexpression under EGF-deprived
conditions, further supporting this model-generated hypothesis.
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Introduction
EGF receptor (ErbB1) and other members of the ErbB family of
receptor tyrosine kinases (RTKs) play essential physiological roles
in development and maintenance of epithelial tissues by generat-
ing cell proliferation, survival, differentiation and migration signals
in response to specific ligands and via the stimulation of several
signaling pathways including PI3K/Akt, MAPK, Src, as well as
STAT pathways [1,2]. Activation of ErbB receptors is also linked
to the initiation and progression of human cancers. Thus,
elucidating signaling pathways that play critical roles in physio-
logical and oncogenic signaling by the ErbB family of receptors is
of substantial clinical significance [2–5]. Despite substantial
progress through experimental studies, in depth mechanistic
analyses of the signaling mechanisms of ErbB receptor family
have been quite challenging due to the multiple interactions
between members of the family, the number of associated effector
pathways, and the complexity of regulatory mechanisms [6]. In
addition to a multitude of positive signaling pathways triggered by
ErbB receptor activation, ErbB receptor signaling is also under
regulation by negative feedback mechanisms via receptor endo-
cytosis and recycling/degradation, and this mechanism is critical
for normal function [7]. The level of intricacy of the ErbB
signaling system is further multiplied by the fact that ErbB
signaling pathways are closely intertwined with a number of other
signaling pathways such as those downstream of integrins and G-
Protein-coupled Receptors [8]. Together, these complexities have
hampered our basic understanding of ErbB receptor signaling and
our ability to develop treatments for diseases, such as breast
cancer, lung cancer, gliomas and others, associated with aberrant
ErbB receptor signaling.
An example of the complex biology of ErbB receptor signaling
that is highly relevant to their role in oncogenesis involves the non-
receptor tyrosine kinase c-Src. The c-Src kinase is overexpressed
or hyperactive in a range of human tumors, including breast
cancer where as many as 70% cases have been reported with c-Src
overexpression along with EGFR/ErbB1 or ErbB2, leading to
conjectures of possible synergy between Src and the ErbBs in
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breast cancer [9]. Indeed, in rodent fibroblasts [9,10] and more
importantly in untransformed human mammary epithelial cells
[11] the overexpression of c-Src promotes ErbB1/EGFR-depen-
dent oncogenic transformation. In particular, c-Src is a critical
component in the regulation of cell survival, proliferation as well as
migration, invasion and metastasis via the regulation of a number
of signaling pathways including PI3K/Akt, MAPK, as well as focal
adhesion kinase (FAK) [12]. However, the interconnectivity of
pathways associated with c-Src and the ErbB signaling has
hindered the determination of the mechanisms of ErbB-c-Src
synergy in cancer.
These difficulties represent an ideal example of the need for a
systems biology approach to ErbB receptor signaling. Because
ErbB1/EGFR has been extensively studied over the last several
decades, it is perhaps one of the best understood receptor tyrosine
kinase systems; this makes it a good candidate for computational
modeling [13]. Thus far, several EGFR-based computational
models have been created; these have been used in studies focusing
on receptor trafficking and endocytosis [14–17], ErbB dimeriza-
tion [18–20], as well as the relationships between physiological
responses and the receptor activation dynamics [21–23]. Several
modeling efforts have also been made to better understand the
signaling events downstream of EGFR [18,24–28]. In addition,
recent efforts also utilized a logical modeling approach to analyze
the topology and dynamics of an ErbB signaling network in
human liver cells [29], and to identify a potential new drug target,
c-MYC, in a model of ErbB receptor-mediated G1/S cell cycle
transition [30].
In this work, a new comprehensive, multi-scale logical model of
signal transduction in a human mammary epithelial cell (hMEC) is
presented. This large-scale dynamical model consists of 245
cellular components and about 1,100 biochemical interactions,
and encompasses all ErbB receptor family members, including
individual receptor phosphorylation sites, as well as integrin, G-
protein-coupled receptor, and stress signaling pathways. The
model was constructed manually by collecting and integrating
biochemical information from over 800 published papers. One of
the main advantages of logical models lies in their scalability; first,
they are based on qualitative information available for many
cellular components across many cell types and do not depend on
kinetic parameters (that are only sparsely available), and second,
simulations of logical models are relatively efficient [31,32],
making this approach appropriate for large systems.
Simulations of the model indicate a relatively accurate depiction
of the complexities of ErbB signaling by integrating a number of
other signaling pathways such as G-protein-coupled receptors
(GPCR) and integrins. Following its validation, the model was
used to generate predictions about the role of c-Src in EGFR
signaling, which were verified experimentally in the laboratory.
Finally, the model (including its governing logical expressions as
well as all annotations) is available on-line in The Cell Collective
software (www.thecellcollective.org; [32]) not only for download in
multiple open formats (e.g., SBML; [33]) , but also for live
simulations.
Results
1. The hMEC model
The hMEC model for EGFR signaling networks in a human
mammary epithelial cell was created by manually collecting
information on local biochemical interactions (e.g., protein-
protein) from the primary literature (using the same methods as
described in [34]). All interactions and logical expressions have
been cataloged and annotated, and are available in the Cell
Collective software [32]. In addition, all representing logical
expressions are available in Supporting Information S1. The
model contains a number of integrated signaling pathways at the
level of protein-protein as well as -post-translational (namely
phosphorylation) site interactions. These pathways include E-
cadherin, ErbB (1–4), ErbB1 (EGFR) endocytosis, G-protein-
coupled Receptor, integrin, and stress signaling pathways
(Figure 1). Detailed description of some of these follows below.
ErbB receptors. All known individual ErbB receptors
(ErbB1–4), as well as the major ErbB receptor dimers were
included in the model. Moreover, the hierarchy of the dimeriza-
tion process [35] was also captured via the logical functions
associated with each receptor node in the model (see the Model
Validation section). Furthermore, this model goes into an even
greater detail; all major (auto) phosphorylation sites of the ErbB
receptors were included. This allows for a range of mutational
studies at the phosphorylation site level in future studies; for
example, this multi-scale property of the mode will enable in silico
simulations and analyses of system-wide effects of all theoretically
possible combinations of virtual knock-out studies of the main
phosphorylation sites in a single receptor as well as across all ErbB
receptors.
EGFR endocytosis. EGFR endocytosis as a potential mech-
anism of negative regulation through lysosomal degradation is
extremely important in relation to oncogenic signaling by ErbB
receptors [6]. Modeling receptor endocytosis is not trivial as the
same receptor can localize into different areas of the cell (e.g.,
clathrin-coated (CC) pits, CC vesicles, endosome, etc.), depending
on its stage of the endocytic trafficking. The way these multiple
localizations are handled using our modeling framework is to
represent EGFR with multiple nodes depicting the receptor in the
different locations during endocytic traffic. Specifically, the
locations included in the model are the following: the plasma
membrane, clathrin-coated pits, clathrin-coated vesicles, early
endosome, late endosome/multivesicular bodies (MVBs), and the
lysosome. The node representing EGFR in the lysosome denotes
the degradation process of EGFR. Because results from these
models do not attempt to predict exact measurements such as
concentrations of ligands used in laboratories, during a simulation,
the activity level associated with, for example, the node
representing EGFR in the lysosome corresponds to the degree of
EGFR being degraded in a semi-quantitative fashion. Further-
more, the type of ligand which activates EGFR has an effect on
whether the receptor is recycled back to cell surface or degraded
upon its internalization. To be able to simulate these effects in
addition to the nodes representing the different localizations of the
receptor during endocytosis, nodes depicting the receptor being
activated by different types of ligands (using EGF or TGFa as
prototypes) were added. Thus there is a node that represents
EGFR on the plasma membrane activated by EGF and a node for
EGFR activated by TGF-alpha. While these differentiations add
complexity to the model, they allow the visualization and study of
the dynamics of the model in greater detail.
Drugs and Antibodies. Therapeutic agents that impact
ErbB receptor signaling and/or traffic, such as humanized anti-
ErbB2 monoclonal antibodies Herceptin and Pertuzumab, as well
as small molecular inhibitors are included in the presented model.
These components allow the simulation of mutations known to
cause cancer while at the same time introducing a number of
different levels and combinations of drugs and observing their
effects on the dynamics of the system.
In summary, the initial version of the new model of signal
transduction in human MEC comprises 240+ biological species
and 1,100+ biochemical interactions. The amount of detail
A Dynamical Model of Signal Transduction in hMEC
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accomplished by including individual phosphorylation sites,
various localizations, as well as dimers of ErbB receptors, and
the scale in terms of the number of the different pathways included
makes this model, to our best knowledge, the most comprehensive
dynamic model of signal transduction available to date.
2. Model Validation
The model was constructed using only information from the
primary literature about local interactions. In other words, during
the construction phase of the model there was no attempt to
determine the local interactions based on any other larger
phenotypes or phenomena. However, after the model was
completed, verification of the accuracy of the model involved
testing it for the ability to reproduce complex input-output
phenomena that have been observed in the laboratory. To do this,
The Cell Collective’s ‘‘Dynamical Analysis’’ simulation feature
was used [32]. This simulation component allows users to simulate
virtual cells under tens of thousands of cellular conditions, and
analyze and visualize the results in terms of input-output dose-
response curves that make it easy to determine whether the virtual
cell behaves as expected. The presented hMEC model was
interrogated to ensure that it is able to reproduce some of the
known global biological phenomena as previously observed
experimentally (Figure 2), including EGF-induced activation of
Figure 1. Graph representation of the model. The purpose of this graph is to visualize the complexity of the model, rather than to read the
individual interactions. This graph representation of the model was generated in Gephi (www.gephi.org).
doi:10.1371/journal.pone.0061757.g001
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Akt and Erk, EGF-independent regulation of Erk via activated
Ras, integrin-dependent stimulation of Erk, Rac, and Cdc42, G-
protein Coupled Receptor activation of adenylyl cyclase, as well as
ErbB receptor dimerization hierarchy. Clearly, one cannot expect
that all phenomena will be replicated by the virtual cell due to the
fact that the model does not represent the entire cell. Hence, the
reproducibility of certain phenomena by the model only indicates
that the model is on the right track.
3. Use of the model to form laboratory-testable
predictions
Once a functional model of hMEC signaling was completed, we
used it to generate predictions about the system that could be
subsequently tested in the laboratory. In this work, the conjecture
of possible synergy between Src and the ErbBs in breast cancer
(described in the introduction) was explored using the model.
Specifically, the question examined was whether the internaliza-
tion of EGFR increases as a result of Src overexpression; this was
based on studies done in fibroblasts that showed increased EGFR
Figure 2. Validation of the MEC model against known cellular phenomena. A) EGF-dependent stimulation of survival signals via activation
of Akt. B) Activation of Erk by EGF [52]. Although a positive relationship between Erk and the ligand can be seen, the activation Erk by EGF seems to
exhibit a more complex dynamics than the ones seen in the other diagrams (i.e., the positive relationship is exhibited when EGF activity levels are 0–
40%). This is, however, not surprising given the complex interactions and cross-communication within the ErbB signaling family. C) Activating
mutations of known protooncogenes such as Ras result in growth factor-independent activation of Erk [53]. D) Erk dependency on signaling via
integrins by extracellular matrix (ECM) [54]. E and F) Activation of Rac and Cdc42 by ECM [55]. G) Positive relationship between Adenylyl Cyclase (AC)
and the G-Protein Coupled Receptor ligand alpha-s [56,57]. H) Hierarchy of ErbB receptor dimerization. The panel on the left represents a system with
EGFR expression alone and, thus, the formation of EGFR homodimers. The expression of ErbB2 (middle panel) results in the shift of the formation
(activity) from EGFR homodimers (EGFR-EGFR) to the formation of EGFR-ErbB2 heterodimers. Furthermore, the expression of ErbB 1–3 results in the
dominant formation of ErbB2–3 heterodimers [13,35]. Note that the references refer to classical, qualitative input-output relationships (not necessarily
quantitative dose–response curves), and the dose-response curves presented here are intended to demonstrate how the computational model
qualitatively reproduces the referenced input-output relationships over a range of stimulus signals.
doi:10.1371/journal.pone.0061757.g002
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internalization in response to sub-saturating levels of EGF when
Src was overexpressed [36], but this phenomenon has not been
investigated in the more relevant MECs nor has it been tested at
low levels/in the absence of added EGF. To test whether the level of
Src activity affects EGFR endocytosis, the node representing c-Src
was constitutively activated in the model, using the Cell
Collective’s Dynamical Analysis feature. The model was then
simulated in The Cell Collective, and the activity levels of EGF-
activated EGFR homodimer on i) the plasma membrane, ii) in
clathrin-coated pits, iii) clathrin-coated vesicles, and iv) the
endosome were measured. The experiment was first conducted
with high levels of EGF to ensure that the model could predict the
known increase in internalization of EGFR under that condition.
The model was then simulated with low levels of EGF activity
(randomly ranging from 0–5%ON). As can be seen in Figure 3,
under both high and low levels of EGF, the overexpression of Src
(i.e., mutating Src to be constitutively-active) leads to the decrease
of the activity levels of the node representing EGFR homodimers
on the plasma membrane, while increasing the % ON levels of
nodes representing the receptor during the internalization process.
Thus the model indicates that Src overexpression will lead to
increased internalization of EGFR even in the absence (or low
levels) of EGF, a result that we assessed and confirmed
experimentally as discussed in the next section.
4. Verification of model-generated predictions
We sought to verify whether the predicted enhancement of the
intracellular (endocytosed) EGFR pools is seen in an actual human
MEC model in laboratory experiments. The overall levels of
ectopically expressed EGFR and Src in 76NTERT human MEC
lines retrovirally transuced with EGFR or EGFR plus Src (using
retroviral infection) [37] were assessed using Western blotting. As
is clear in Figure 4, increased Src and EGFR levels are observed in
the appropriate transductants. As expected, both the EGFR alone
transduced as well as the EGFR plus Src transduced cell lines
showed higher EGFR levels compared to the parent 76NTERT
cell line (Figure 4; results further explained in the caption).
Notably, the total levels of biochemically detected EGFR in the
EGFR plus Src transductant (lane 3) exceed the levels of EGFR
detectable in the EGFR alone transductant. In contrast, Fluores-
cence-activated cell sorting (FACS) based analysis that was
designed to selectively measure the levels of EGFR on the cell
surface (FACS analysis was done on live cells without permabiliz-
ing them; under these conditions, the staining antibody is excluded
from endocytosed pools of EGFR) demonstrated that, in the
absence of added EGF, there is dramatically reduced expression of
EGFR on the surface of MECs overexpressing Src (Figure 5, third
panel of the second row; indicated by the lower median
fluorescence channel values along the X-axis – MFI= 276)
compared to EGFR-only transduced MEC controls (Figure 5,
second panel of the second row, which expectedly shows a
markedly higher median channel value of 528 compared to112 in
untransduced control in the first panel). Thus, the prediction from
the hMEC model, that higher levels of Src introduced into MECs
will lead to a lower proportion of EGFR at the cell surface even in
the absence of EGF, i.e., EGFR is internalized, is fully verified by
experimental analyses of an actual mammary epithelial cell system.
Discussion
The critical roles of ErbB receptors in physiological processes
and the importance of their overexpression and/or hyperactivity
in the initiation and progression of cancers makes analyses of these
receptor tyrosine kinases extremely significant. EGFR is also the
most highly studied prototype of receptor tyrosine kinase signaling.
Therefore, predictive computational modeling of signaling down-
stream of these receptors in the context of positive and negative
loops and cross-talk with other receptor systems are likely to
greatly enhance our fundamental knowledge of cellular signaling
in health and disease. These models can also provide a more
informed platform for therapeutic targeting of aberrant ErbB
signaling in cancer to reduce treatment failures and to stem the
emergence of resistance. Here, we present a new and most
comprehensive computational model of ErbB receptor signaling in
a human mammary epithelial cell, use simulations to make a
specific prediction on the biological behavior of a hMEC under
experimental conditions that model the overexpression of EGFR
and Src as seen in human cancers, and then use laboratory
experiments to fully verify the prediction.
It is well-established that EGFR and c-Src tyrosine kinase are
co-overexpressed in human cancers, and experimental modeling
of their co-overexpression in untransformed hMECs in the
laboratory leads to their collaborative promotion of oncogenesis
[11]. Studies in such systems will be greatly enhanced by
generating hypotheses on the interactions of the two oncogenic
proteins that can be experimentally tested. As RTK signaling is
spatio-temporally regulated in part by the subcellular location of
activated receptors in different endocytic compartments which
serves as a critical determinant of the level and diversity of their
Figure 3. EGFR internalization effects by Src overexpression.
Experiments were conducted under conditions for which the expression
of ErbB2–4 was turned off and the virtual cell stimulated with EGF. A)
Stimulation of the virtual cell with low levels of EGF (0–5%). B) EGF was
introduced to the model in randomly selected high activity levels (60–
70% ON). * p,0.05 (Student’s t-test; n= 300; error bars represent the
standard error of the mean). Note: PM corresponds to EGFR
homodimers on the plasma membrane, CCP represents the homodimer
in clathrin-coated pits, CCV – clathrin-coated vesicles, and MVB – EGFR
homodimer in late endosome/multivescicular bodies.
doi:10.1371/journal.pone.0061757.g003
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signaling outputs [37,38]. Therefore, we used the computational
model that we have developed to specifically address questions of
endocytic localization of EGFR under the influence of Src.
It is remarkable that the model could make an accurate de novo
prediction that the elevated Src activity will promote the
localization of EGFR in internal compartments of the endocytic
pathways even in the absence of added ligand. We used a cell
system in which we utilized an externally-introduced EGFR
(under a viral promoter) to test this prediction. Even though the
total levels of EGFR are substantially higher in the cell line that co-
overexpresses Src (Figure 4), the levels of EGFR on the cell surface
are dramatically reduced (Figure 5); thus, a vast majority of EGFR
in these cells is predicted to be in endocytic compartments even
without an added ligand. Under normal conditions, ligands such
as EGF cause rapid internalization of EGFR and its rapid
degradation in the lysosome while other ligands such as TGFalpha
or amphiregulin promote less degradation with more recycling
[39]. Notably, increased internal pools of EGFR are a feature of
oncogenic mutants of EGFR; we have recently shown that human
non-small cell lung cancer cell lines harboring EGFR mutants with
activating kinase domain mutations show increased levels of active
EGFR within intracellular endocytic compartments when cultured
without external EGF [40]. Remarkably, the internalized pool of
oncogenic EGFR co-localized with active Src [40] and the
interaction of mutant EGFR and Src was required for efficient
oncogenic transformation of fibroblasts [41]. Thus, our current
model-based prediction followed by experimental verification in a
relevant cell model in the laboratory should open a productive
lead to further experimentation towards understanding how Src
and EGFR cooperate in oncogenesis. Importantly, the verified
experimental findings can then be incorporated back into our
computational model to enhance its ability to make further
predictions and efforts along these lines are underway.
The use of computational models to generate experimentally
testable hypotheses in an information flow cycle from laboratories
to computational models and back to laboratories [42] is an
important dynamic that will define the future of computational
systems biology. However, the sheer size and complexity of
biochemical and biological processes poses a barrier for one
person or group to create and/or expand in an effective way large-
scale dynamical models of these systems. While the presented
model is one of the largest computational models created, it merely
represents a small fraction of the cell. Similar to Wikipedia and
open source software – both of which are centered around large
amounts of knowledge that could not have originated from one
single person or group, one way to create larger computational
models of biological process, ones that have the potential to
eventually lead to whole-cell models, is to engage the scientific
community in a collaborative fashion. Hence, the presented
hMEC model has been made available in The Cell Collective
software which was designed precisely to enable such a collabo-
rative and collective approach to systems biology [32]. The model
is available to the entire scientific community via the software for
further expansion, refinements, as well as simulations and analyses.
The user-friendly interface of the software allows users to make
changes to the model without any need to enter complex
mathematical equations or computer code, making it accessible
to experimental scientists who have the most intimate knowledge
of the local data to improve and grow this model (and others
available in the software platform; e.g., [30,43,44]).
Materials and Methods
1. Model construction via The Cell Collective
The presented model is based on a common qualitative
(discrete) modeling technique where the regulatory mechanism
of each node is described by a Boolean expression (for more
comprehensive information on Boolean modeling see for example
[45,46]). The construction of the model was accomplished using
The Cell Collective (www.thecellcollective.org; [32]), a collabora-
tive modeling platform for large-scale biological systems. The
platform allows users to construct and simulate large-scale
computational models of various biological processes based on
qualitative interaction information using the platform’s Bio-Logic
Builder which converts the entered qualitative biochemical
information into Boolean expressions in the background [47].
(Though the Boolean expressions for any model created in the
platform can be downloaded from the website.) This non-technical
creation and representation of the individual interactions in the
model make it especially easy for experimental biologists to
contribute to the creation of the model without the need for
training in the underlying mathematical formalisms. The model
has been exported and is also available as part of this manuscript
in a SBML format for qualitative models (Supporting Information
S2).
The Cell Collective’s Knowledge Base component was also used
to catalog and annotate all biochemical/biological information for
signaling in hMECs as mined from the primary literature. Each
Figure 4. Src overexpression does not affect total EGFR levels.
Parental 76N-TERT cells or its EGFR or EGFR + Src transductants were
EGF deprived by culture in the EGF-deficient D3 medium for 48 hrs and
cell lysates were prepared. 50 mg aliquots of cell lysate protein were run
on an 8% SDS PAGE gel and immunoblotted with anti-EGFR (top panel)
or anti-Src (middle panel). Membrane was re-probed with anti-beta
actin (bottom panel) to ensure equal loading.
doi:10.1371/journal.pone.0061757.g004
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model species in the Knowledge Base has its own wiki-like page
where information on the individual interactions is stored,
including references.
2. Model Simulations and Analysis
In addition to the model building and cataloging process, The
Cell Collective platform was also used to perform all computa-
tional simulations of the hMEC model. While the dynamical
model is based on a discrete (i.e., Boolean) formalism, as can be
seen in the results, the simulation input and output data are
continuous. This was accomplished by converting the digital
output of the model simulations to % activity (% ON) which
ranges (for each model component) from 0 to 100 [31,34]. It is
important to note that the % ON doesn’t directly correspond to
the biological concentration or any other measurable property,
rather the % ON provides a semi-quantitative measure to describe
the relative activity level of a particular protein. As such, the model
output (species activity levels) is compared to previously published
experimental findings as well as the experimental results presented
herein by assessing the directionality of the changes (up-/down-
regulation) of species activity relative to the wild-type. All
simulations were conducted using a biologically relevant initial
condition as discussed in [34]; this condition is also accessible via
The Cell Collective software. All in silico experiments were
performed under external conditions (Table 1) that were
optimized for the particular experiment [34].
3. Establishment of mammary epithelial cell lines
overexpressing EGFR or EGFR plus Src
Human telomerase reverse transcriptase (TERT) immortalized
76N normal human MEC line 76N-TERT has been previously
described [48,49]. These cells were cultured in DFCI-1 medium
and the human EGFR or EGFR plus c-Src were overexpressed in
these cells using retroviral infection as described previously [50].
4. Assessment of Src overexpression and EGFR levels
using Western blotting
Parental 76NTERT cell line or its EGFR or EGFR + Src
transductants were growth factor deprived for 48 h (with medium
change each day) in EGF-deficient D3 medium (DFCI-1 medium
lacking insulin, hydrocortisone, EGF and bovine pituitary extract)
Figure 5. Surface expression of EGFR is reduced in Src-transfected cells. FACS analysis of the cell surface expression of EGFR in MEC
transductants shows (in row 2) that Src overexpression leads to a reduction in the level of EGFR at the cell surface despite higher total EGFR levels
detected biochemically (shown in Figure 3). Cells were EGF-deprived by culture in D3 medium for 48 h, after which single cell suspensions were
prepared with trypsin/EDTA. Live cells were stained with isotype-matched control monoclonal antibodies or with anti-EGFR monoclonal antibody for
1 hr.., washed and incubated with the secondary antibody (PE-conjugated) for 45 min., and analyzed by FACS to determine cell surface levels of
EGFR. Numbers in the right top corner of each FACS panel indicate median fluorescence channel intensity (higher numbers indicating higher levels
and vice versa). Initial experiments (not shown) established the specificity of antibodies.
doi:10.1371/journal.pone.0061757.g005
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[51], Cell lysates were prepared in a Triton X-100-based lysis
buffer, and 50 mg aliquots of cell lysate protein were run on an 8%
SDS PAGE gel and immunoblotted with anti-EGFR, anti-Src and
anti-beta actin antibodies, as described [50].
5. Assessment of surface expression of EGFR
Cells were cultured under EGF-deprivation conditions as above
for 48 h, and single cell suspensions were prepared by releasing
cells from tissue culture plates with trypsin/EDTA. Live cells were
stained on ice with isotype-matched control monoclonal antibodies
or with anti-EGFR monoclonal antibody (clone 528; ATCC) for
1 h, washed and incubated with the secondary antibody (PE-
conjugated anti-mouse IgG) for 45 min followed by FACS analysis
(using a FACSCalibur instrument) to determine the relative cell
surface EGFR levels.
Supporting Information
Supporting Information S1 A comprehensive, multi-scale
dynamical model of ErbB receptor signal transduction in human
mammary epithelial cells
(DOC)
Supporting Information S2 SBML model representation of
signal transduction epithelial cells
(SBML)
Author Contributions
Conceived and designed the experiments: TH JAR HB MN SMR VB
MD. Performed the experiments: TH NK JAR HB MN SMR VB MD.
Analyzed the data: TH JAR HB MN SMR VB MD. Contributed
reagents/materials/analysis tools: TH BK JAR HB MN SMR VB MD.
Wrote the paper: TH JAR HB.
References
1. Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of
targeted inhibitors. Nature reviews Cancer 5: 341–354. doi:10.1038/nrc1609.
2. Hynes NE, MacDonald G (2009) ErbB receptors and signaling pathways in
cancer. Curr Opin Cell Biol 21: 177–184.
3. Stern DF (2000) Tyrosine kinase signalling in breast cancer: ErbB family
receptor tyrosine kinases. Breast Cancer Res 2: 176–183.
4. Yarden Y (2001) Biology of HER2 and its importance in breast cancer.
Oncology 61 Suppl 2: 1–13.
5. Holbro T, Beerli RR, Maurer F, Koziczak M, Barbas CF 3rd, et al. (2003) The
ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires
ErbB3 to drive breast tumor cell proliferation. Proc Natl Acad Sci U S A 100:
8933–8938.
6. Yarden Y, Sliwkowski MX (2001) Untangling the ErbB signalling network. Nat
Rev Mol Cell Biol 2: 127–137.
7. Sorkin A, Von Zastrow M (2009) Endocytosis and signalling: intertwining
molecular networks. Nat Rev Mol Cell Biol 10: 609–622.
8. Wertheimer E, Gutierrez-Uzquiza A, Rosemblit C, Lopez-Haber C, Sosa MS,
et al. (2012) Rac signaling in breast cancer: a tale of GEFs and GAPs. Cellular
signalling 24: 353–362. doi:10.1016/j.cellsig.2011.08.011.
9. Biscardi JS, Ishizawar RC, Silva CM, Parsons SJ (2000) Tyrosine kinase
signalling in breast cancer: epidermal growth factor receptor and c-Src
interactions in breast cancer. Breast Cancer Res 2: 203–210.
10. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ (1995)
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-
Src: implications for the etiology of multiple human cancers. Proceedings of the
National Academy of Sciences of the United States of America 92: 6981–6985.
11. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, et al. (2007) Modeling
breast cancer-associated c-Src and EGFR overexpression in human MECs: c-
Src and EGFR cooperatively promote aberrant three-dimensional acinar
structure and invasive behavior. Cancer research 67: 4164–4172.
doi:10.1158/0008-5472.CAN-06-2580.
12. Wheeler DL, Iida M, Dunn EF (2009) The role of Src in solid tumors.
Oncologist 14: 667–678.
13. Wiley HS, Shvartsman SY, Lauffenburger DA (2003) Computational modeling
of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol
13: 43–50.
14. Shankaran H, Wiley HS, Resat H (2007) Receptor downregulation and
desensitization enhance the information processing ability of signalling receptors.
BMC Syst Biol 1: 48.
15. Gex-Fabry M, DeLisi C (1984) Receptor-mediated endocytosis: a model and its
implications for experimental analysis. Am J Physiol 247: R768–79.
16. Wiley HS, Cunningham DD (1981) A steady state model for analyzing the
cellular binding, internalization and degradation of polypeptide ligands. Cell 25:
433–440.
17. Wiley HS, Cunningham DD (1982) The endocytotic rate constant. A cellular
parameter for quantitating receptor-mediated endocytosis. J Biol Chem 257:
4222–4229.
18. Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA (2005) Parsing
ERK activation reveals quantitatively equivalent contributions from epidermal
Table 1. External simulation conditions.
Stimulus/Simulation
Experiment Fig. 2A Fig. 2B Fig. 2C Fig. 2D Fig. 2E Fig. 2F Fig. 2G Fig. 2H Fig. 3A Fig. 3B
alpha_1213L 40–60 72 72 60–70 5–65 70–80 36 26 20–30 20–30
alpha_iL 0–10 11 11 70–80 30–80 40–50 69 97 90 100
alpha_qL 0–10 37 37 10–20 50–100 90–100 77 4 1 5
alpha_sL 40–60 48 48 10–20 55–95 50–60 0–100 55 50 60
ECM 0–100 88 88 0–100 0–100 0–100 99 94 90 100
EGF 0–100 0–100 0–100 0 0–100 1–10 10 90–100 0–5 60–70
EGFR_Contr 100 100 100 100 100 100 100 90–100 100 100
ErbB2_Contr 0 0 0 0 0 0 0 0/90–100/90–100 0 0
ErbB2Deg_Contr 0 0 0 0 0 0 0 0/25–35/25–35 0 0
ErbB3_Contr 0 0 0 0 0 0 0 0/0/90–100 0 0
ExtPump 40–60 12 12 1–10 80–100 90–100 94 76 70–80 70–80
IL1_TNF 2 2 2 2 2 2 2 2 2 2
Stress 2 2 2 2 2 2 2 2 2 2
All values represent (%ON) activity levels. Stimuli not used in these experiments were set to 0 and are not listed in the table. Note that while some external conditions
consist of ranges and others of specific values, we find that most experiments are not sensitive to specific values. Using the values provided in this table, all simulated
experiments of the model can be reproduced in The Cell Collective software.
doi:10.1371/journal.pone.0061757.t001
A Dynamical Model of Signal Transduction in hMEC
PLOS ONE | www.plosone.org 8 April 2013 | Volume 8 | Issue 4 | e61757
growth factor receptor and HER2 in human mammary epithelial cells. J Biol
Chem 280: 6157–6169.
19. Hendriks BS, Opresko LK, Wiley HS, Lauffenburger D (2003) Coregulation of
epidermal growth factor receptor/human epidermal growth factor receptor 2
(HER2) levels and locations: quantitative analysis of HER2 overexpression
effects. Cancer Res 63: 1130–1137.
20. Shankaran H, Wiley HS, Resat H (2006) Modeling the effects of HER/ErbB1-3
coexpression on receptor dimerization and biological response. Biophys J 90:
3993–4009.
21. Knauer DJ, Wiley HS, Cunningham DD (1984) Relationship between
epidermal growth factor receptor occupancy and mitogenic response. Quanti-
tative analysis using a steady state model system. J Biol Chem 259: 5623–5631.
22. Starbuck C, Lauffenburger DA (1992) Mathematical model for the effects of
epidermal growth factor receptor trafficking dynamics on fibroblast proliferation
responses. Biotechnol Prog 8: 132–143.
23. Waters CM, Overholser KA, Sorkin A, Carpenter G (1992) Analysis of the
influences of the E5 transforming protein on kinetic parameters of epidermal
growth factor binding and metabolism. J Cell Physiol 152: 253–263.
24. Bhalla US, Iyengar R (1999) Emergent properties of networks of biological
signaling pathways. Science 283: 381–387.
25. Kholodenko BN, Demin O V, Moehren G, Hoek JB (1999) Quantification of
short term signaling by the epidermal growth factor receptor. J Biol Chem 274:
30169–30181.
26. Haugh JM, Huang AC, Wiley HS, Wells A, Lauffenburger DA (1999)
Internalized epidermal growth factor receptors participate in the activation of
p21(ras) in fibroblasts. J Biol Chem 274: 34350–34360.
27. Schoeberl B, Eichler-Jonsson C, Gilles ED, Mu¨ller G (2002) Computational
modeling of the dynamics of the MAP kinase cascade activated by surface and
internalized EGF receptors. Nat Biotechnol 20: 370–375.
28. Wang DYQ, Cardelli L, Phillips A, Piterman N, Fisher J (2009) Computational
modeling of the EGFR network elucidates control mechanisms regulating signal
dynamics. BMC Syst Biol 3: 118.
29. Samaga R, Saez-Rodriguez J, Alexopoulos LG, Sorger PK, Klamt S (2009) The
logic of EGFR/ErbB signaling: theoretical properties and analysis of high-
throughput data. PLoS Comput Biol 5: e1000438.
30. Sahin O, Fro¨hlich H, Lo¨bke C, Korf U, Burmester S, et al. (2009) Modeling
ERBB receptor-regulated G1/S transition to find novel targets for de novo
trastuzumab resistance. BMC Syst Biol 3: 1.
31. Helikar T, Rogers JA (2009) ChemChains: a platform for simulation and
analysis of biochemical networks aimed to laboratory scientists. BMC Syst Biol
3: 58.
32. Helikar T, Kowal B, McClenathan S, Bruckner M, Rowley T, et al. (2012) The
Cell Collective: Toward an open and collaborative approach to systems biology.
BMC systems biology 6: 96. doi:10.1186/1752-0509-6-96.
33. Finney A, Hucka M (2003) Systems biology markup language: Level 2 and
beyond. Biochemical Society transactions 31: 1472–1473. doi:10.1042/.
34. Helikar T, Konvalina J, Heidel J, Rogers JA (2008) Emergent decision-making
in biological signal transduction networks. Proc Natl Acad Sci U S A 105: 1913–
1918.
35. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, et al. (1996) A
hierarchical network of interreceptor interactions determines signal transduction
by Neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell
Biol 16: 5276–5287.
36. Ware MF, Tice DA, Parsons SJ, Lauffenburger DA (1997) Overexpression of
cellular Src in fibroblasts enhances endocytic internalization of epidermal growth
factor receptor. J Biol Chem 272: 30185–30190.
37. Sorkin A, Goh LK (2008) Endocytosis and intracellular trafficking of ErbBs.
Experimental cell research 314: 3093–3106. doi:10.1016/j.yexcr.2008.08.013.
38. Roepstorff K, Grøvdal L, Grandal M, Lerdrup M, Van Deurs B (2008)
Endocytic downregulation of ErbB receptors: mechanisms and relevance in
cancer. Histochemistry and cell biology 129: 563–578. doi:10.1007/s00418-008-
0401-3.
39. Zwang Y, Yarden Y (2009) Systems biology of growth factor-induced receptor
endocytosis. Traffic (Copenhagen, Denmark) 10: 349–363. doi:10.1111/j.1600-
0854.2008.00870.x.
40. Chung BM, Raja SM, Clubb RJ, Tu C, George M, et al. (2009) Aberrant
trafficking of NSCLC-associated EGFR mutants through the endocytic recycling
pathway promotes interaction with Src. BMC cell biology 10: 84. doi:10.1186/
1471-2121-10-84.
41. Chung BM, Dimri M, George M, Reddi AL, Chen G, et al. (2009) The role of
cooperativity with Src in oncogenic transformation mediated by non-small cell
lung cancer-associated EGF receptor mutants. Oncogene 28: 1821–1832.
doi:10.1038/onc.2009.31.
42. Di Ventura B, Lemerle C, Michalodimitrakis K, Serrano L (2006) From in vivo
to in silico biology and back. Nature 443: 527–533.
43. Todd RG, Helikar T (2012) Ergodic sets as cell phenotype of budding yeast cell
cycle. PloS one 7: e45780. doi:10.1371/journal.pone.0045780.
44. Madrahimov A, Helikar T, Kowal B, Lu G, Rogers J (2012) Dynamics of
Influenza Virus and Human Host Interactions During Infection and Replication
Cycle. Bulletin of mathematical biology In press. doi:10.1007/s11538-012-9777-
2.
45. Morris MK, Saez-Rodriguez J, Sorger PK, Lauffenburger DA (2010) Logic-
based models for the analysis of cell signaling networks. Biochemistry 49: 3216–
3224. doi:10.1021/bi902202q.
46. Helikar T, Kochi N, Konvalina J, Rogers JA (2011) Boolean Modeling of
Biochemical Networks. The Open Bioinformatics Journal 4: 16–25.
47. Helikar T, Kowal B, Madrahimov A, Shrestha M, Pedersen J, et al. (2012) Bio-
logic builder: a non-technical tool for building dynamical, qualitative models.
PloS one 7: e46417. doi:10.1371/journal.pone.0046417.
48. Zhao X, Malhotra GK, Lele SM, Lele MS, West WW, et al. (2010) Telomerase-
immortalized human mammary stem/progenitor cells with ability to self-renew
and differentiate. Proceedings of the National Academy of Sciences of the
United States of America 107: 14146–14151. doi:10.1073/pnas.1009030107.
49. Ratsch SB, Gao Q, Srinivasan S, Wazer DE, Band V (2001) Multiple genetic
changes are required for efficient immortalization of different subtypes of normal
human mammary epithelial cells. Radiation research 155: 143–150.
50. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, et al. (2007) Modeling
breast cancer-associated c-Src and EGFR overexpression in human MECs: c-
Src and EGFR cooperatively promote aberrant three-dimensional acinar
structure and invasive behavior. Cancer research 67: 4164–4172.
doi:10.1158/0008-5472.CAN-06-2580.
51. Band V, Sager R (1989) Distinctive traits of normal and tumor-derived human
mammary epithelial cells expressed in a medium that supports long-term growth
of both cell types. Proceedings of the National Academy of Sciences of the
United States of America 86: 1249–1253.
52. Roux PP, Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a
family of protein kinases with diverse biological functions. Microbiology and
molecular biology reviews: MMBR 68: 320–344. doi:10.1128/
MMBR.68.2.320-344.2004.
53. Sridhar SS, Hedley D, Siu LL (2005) Raf kinase as a target for anticancer
therapeutics. Molecular cancer therapeutics 4: 677–685. doi:10.1158/1535-
7163.MCT-04-0297.
54. Edin ML, Juliano RL (2005) Raf-1 serine 338 phosphorylation plays a key role in
adhesion-dependent activation of extracellular signal-regulated kinase by
epidermal growth factor. Molecular and cellular biology 25: 4466–4475.
doi:10.1128/MCB.25.11.4466-4475.2005.
55. Price LS, Leng J, Schwartz MA, Bokoch GM (1998) Activation of Rac and
Cdc42 by integrins mediates cell spreading. Molecular biology of the cell 9:
1863–1871.
56. Selbie LA, Hill SJ (1998) G protein-coupled-receptor cross-talk: the fine-tuning
of multiple receptor-signalling pathways. Trends in pharmacological sciences 19:
87–93.
57. Milligan G, White JH (2001) Protein-protein interactions at G-protein-coupled
receptors. Trends in pharmacological sciences 22: 513–518.
A Dynamical Model of Signal Transduction in hMEC
PLOS ONE | www.plosone.org 9 April 2013 | Volume 8 | Issue 4 | e61757
